A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This first-in-human study is designed to evaluate the safety, tolerability, pharmacokinetics and target engagement of ETH47 in healthy participants following single intranasal and single inhaled administration
Epistemonikos ID: 08a731ef7e37f6366df1d89f17eb790a65c25c9d
First added on: Jul 09, 2025